Collectively, these data demonstrated that miR-153 expression was down-regulated in GSCs compared with that of non-GSCs glioma cells, which contributed to enhanced Nrf-2 expression resulting in activation of GPx1 transcription. This evidence concerns the gene GPX1 and central nervous system cancer.